Current Opinion in Oncology

Papers
(The H4-Index of Current Opinion in Oncology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?63
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies43
Treatments and challenges in advanced prostate cancer42
Role of PSMA PET/CT in imaging and management of prostate cancer36
Collecting information from all sarcoma reference cancer centres worldwide: achievement and next steps30
Neurorehabilitation in brain tumours: evidences and suggestions for spreading of knowledge and research implementation27
Content features and its implementation in novel app-based psycho-oncological interventions for cancer survivors: a narrative review24
Editorial introductions23
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies21
First and further-line multidisciplinary treatment of retroperitoneal sarcomas21
Psycho-oncology interventions focusing on fatigue and sleep disturbances20
Harnessing dendritic cells for innovative therapeutic cancer vaccines19
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy19
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes18
Beyond ‘the good, the bad and the ugly’: let us put rectal cancer patients at the centre of the decision making17
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis17
0.072931051254272